← Back to Search

Central Blood Pressure Monitoring Devices for Chronic Kidney Disease (CBP-REIN Trial)

Q: Does this research include participants younger than 65 years old?

The limits for participation in this clinical trial are 18 years old and 80 years old respectively.

Q: Who is best suited to engage with this research project?

This clinical research is welcoming 340 volunteers, <a href="https://www.withpower.com/clinical-trials/all">all</a> of whom must be between 18 to 80 years old and having <a href="https://www.withpower.com/clinical-trials/hypertension">hypertension</a>.

Q: How many subjects are presently engaged in this research endeavor?

Affirmative. Information posted to clinicaltrials.gov suggests that the study is currently recruiting patients, having been initially published on April 26th 2021 and most recently edited on July 25th 2023. The trial seeks 340 volunteers from a single medical centre.

Q: Are there currently any vacancies for participants in this clinical trial?

Affirmative. Per the clinicaltrials.gov record, this medical trial is still accepting candidates and was initially posted on April 26th 2021. 340 patients are required to be enrolled at a single site with the most recent update being made July 25th 2023.

N/A

Recruiting

Research Sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-80 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at enrollment (time 0)

Awards & highlights

CBP-REIN Trial Summary

This trial compares BP readings from 4 non-invasive devices to measure central aortic blood pressure. The goal is to determine the accuracy of each device.

Who is the study for?

This trial is for kidney disease patients aged 18-80 who can consent to participate. It's not suitable for those with ongoing atrial fibrillation or an arm circumference that doesn't fit the blood pressure cuffs (<18 cm or >50 cm).Check my eligibility

What is being tested?

The study tests how well four different devices agree on measuring central blood pressure in a non-invasive way. These are Mobil-o-Graph NG, WatchBP Office, BP+ device, and Oscar 2 with SphygmoCor inside.See study design

What are the potential side effects?

Since this trial involves standard non-invasive blood pressure measurements, side effects are minimal but may include temporary discomfort from cuff inflation similar to routine blood pressure checks.

CBP-REIN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

CBP-REIN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at enrollment (time 0)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at enrollment (time 0)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrollment (time 0) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Central SBP difference

Secondary outcome measures

Brachial DBP difference

Brachial SBP difference

Central DBP difference

CBP-REIN Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Hypertension groupExperimental Treatment1 Intervention

Patients with BP > 135/85 mmHg or taking any antihypertensive medication with normal kidney function (eGFR > 60 ml/min/1.73m2)

Group II: Dialysis groupsExperimental Treatment1 Intervention

Patients on hemodialysis or peritoneal dialysis

Group III: Advanced CKD groupExperimental Treatment1 Intervention

Patients with eGFR < 30 ml/min/1.73m2 not on dialysis

Group IV: Control groupActive Control1 Intervention

Normotensive patients without any antihypertensive drugs or chronic kidney disease

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de MontrealLead Sponsor

12 Previous Clinical Trials

4,001 Total Patients Enrolled

Media Library

Advanced CKD group Clinical Trial Eligibility Overview. Trial Name: NCT05963880 — N/A

High Blood Pressure Research Study Groups: Advanced CKD group, Hypertension group, Control group, Dialysis groups

High Blood Pressure Clinical Trial 2023: Advanced CKD group Highlights & Side Effects. Trial Name: NCT05963880 — N/A

Advanced CKD group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05963880 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include participants younger than 65 years old?

"The limits for participation in this clinical trial are 18 years old and 80 years old respectively."

Answered by AI

Who is best suited to engage with this research project?

"This clinical research is welcoming 340 volunteers, all of whom must be between 18 to 80 years old and having hypertension."

Answered by AI

How many subjects are presently engaged in this research endeavor?

"Affirmative. Information posted to clinicaltrials.gov suggests that the study is currently recruiting patients, having been initially published on April 26th 2021 and most recently edited on July 25th 2023. The trial seeks 340 volunteers from a single medical centre."

Answered by AI

Are there currently any vacancies for participants in this clinical trial?

"Affirmative. Per the clinicaltrials.gov record, this medical trial is still accepting candidates and was initially posted on April 26th 2021. 340 patients are required to be enrolled at a single site with the most recent update being made July 25th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Concordance Between Central Blood PRessure dEvices In Nephrology Patients

2021. "Concordance Between Central Blood PRessure dEvices In Nephrology Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05963880.